Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6528
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration ; volume:11 ; number:1 ; day:19 ; month:12 ; year:2021 ; pages:377-386 ; date:2.2022
Ophthalmology and therapy ; 11, Heft 1 (19.12.2021), 377-386, 2.2022
- Urheber
-
Arrigo, Alessandro
Amato, Alessia
Barresi, Costanza
Aragona, Emanuela
Saladino, Andrea
Pina, Adelaide
Calcagno, Francesca
Bandello, Francesco
Battaglia Parodi, Maurizio
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40123-021-00443-1
- URN
-
urn:nbn:de:101:1-2022050109132208503135
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Arrigo, Alessandro
- Amato, Alessia
- Barresi, Costanza
- Aragona, Emanuela
- Saladino, Andrea
- Pina, Adelaide
- Calcagno, Francesca
- Bandello, Francesco
- Battaglia Parodi, Maurizio
- SpringerLink (Online service)
Ähnliche Objekte (12)
Mast cells promote choroidal neovascularization in a model of age-related macular degeneration
Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Activation of a Quiescent Choroidal Neovascularization in a Patient with Age-Related Macular Degeneration
Current Perspectives on Type 3 Macular Neovascularization due to Age-Related Macular Degeneration
CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration
Optical Coherence Tomography Prognostic Factors in Age-Related Macular Degeneration Patients with Peripapillary Choroidal Neovascularization
Brolucizumab for recalcitrant macular neovascularization in age-related macular degeneration with pigment epithelial detachment
Correction to: Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
Growth of nonexudative macular neovascularization in age-related macular degeneration: an indicator of biological lesion activity
Quantitative assessment of choriocapillaris flow deficits and type 1 macular neovascularization growth in age-related macular degeneration
Prediction of activity in eyes with macular neovascularization due to age-related macular degeneration using deep learning
Mast cells promote choroidal neovascularization in a model of age-related macular degeneration
Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Activation of a Quiescent Choroidal Neovascularization in a Patient with Age-Related Macular Degeneration
Current Perspectives on Type 3 Macular Neovascularization due to Age-Related Macular Degeneration
CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration
Optical Coherence Tomography Prognostic Factors in Age-Related Macular Degeneration Patients with Peripapillary Choroidal Neovascularization
Brolucizumab for recalcitrant macular neovascularization in age-related macular degeneration with pigment epithelial detachment
Correction to: Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
Growth of nonexudative macular neovascularization in age-related macular degeneration: an indicator of biological lesion activity
Quantitative assessment of choriocapillaris flow deficits and type 1 macular neovascularization growth in age-related macular degeneration
Prediction of activity in eyes with macular neovascularization due to age-related macular degeneration using deep learning
Mast cells promote choroidal neovascularization in a model of age-related macular degeneration
Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Activation of a Quiescent Choroidal Neovascularization in a Patient with Age-Related Macular Degeneration
Current Perspectives on Type 3 Macular Neovascularization due to Age-Related Macular Degeneration
CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration
Optical Coherence Tomography Prognostic Factors in Age-Related Macular Degeneration Patients with Peripapillary Choroidal Neovascularization
Brolucizumab for recalcitrant macular neovascularization in age-related macular degeneration with pigment epithelial detachment
Correction to: Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
Growth of nonexudative macular neovascularization in age-related macular degeneration: an indicator of biological lesion activity
Quantitative assessment of choriocapillaris flow deficits and type 1 macular neovascularization growth in age-related macular degeneration